Zhonghua Yu

发表

Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study

W. Wang, Jinsheng Hong, Liangfang Shen, 2022, The Lancet regional health. Western Pacific.

Ef ﬁ cacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase 2 study

R. Guo, Jiong Cai, S. Qiu, 2022 .